Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdimFlu-S Immunogenicity in Dialysis Patients
NCT01512056Phase 4Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza virus vaccine, split virion in influenza (3 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Change of antibody titer before and after influenza vaccination at 18 weeks. Status: unknown.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01512056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01512056.